Reduction of intraocular pressure (IOP) in patients with open-angle glaucoma and ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues.
Precautions regarding Indications: As a general rule, single-agent therapy should be given priority.